Richard Greil

Researcher Next ID · RN-007946

Researcher · Medicine

Salzburg, Austria

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Chronic Lymphocytic Leukemia Research

Lymphoma Diagnosis and Treatment

Breast Cancer Treatment Studies

Cancer Treatment and Pharmacology

Advanced Breast Cancer Therapies

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32591-7
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32591-7
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1914609
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70477-1
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0806285

No projects listed.